MeSH D011537 - pruritus
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Able Laboratories | Hydroxyzine | Hydroxyzine |  | 2004-07-22 |  |  |
| Ajanta Pharma | Doxepin | Doxepin |  | 2019-09-13 |  |  |
| Albireo Pharma | Odevixibat | Bylvay |  | 2021-07-16 |  |  |
| Alembic Pharmaceuticals | Doxepin | Doxepin |  | 2021-04-21 |  |  |
| Allergan | Phenylephrine, Pyrilamine | Prefrin-a |  | 1982-01-01 |  |  |
| Doxepin | Doxepin |  | 1987-03-04 |  |  | |
| Hydroxyzine | Hydroxyzine |  | 1994-03-18 |  |  | |
| Hydroxyzine | Hydroxyzine Pamoate |  | 1991-07-31 |  |  | |
| Pyrilamine | Pyrilamine |  | 1982-01-01 |  |  | |
| Alpharma | Hydroxyzine | Hydroxyzine |  | 1988-02-03 |  |  |
| Altana | Hydroxyzine | Hydroxyzine |  | 1982-04-20 |  |  |
1
2
3
4
5
6
...
11
>
Clinical Trials
Historical Success Rate
Phase 1
61%11/18
Phase 2
41%17/41
Phase 3
75%30/40
Approved: 21Overall Success rate: 19%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
8
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use